Company:
Physiomedics Ltd
Management Team:
Garry Fingland, Chairman
Mark Roger, Director
Ross Haworth, Director
Kirsten Lord, Founder & Chief Clinical Officer
Web & Social Media:
www.physiowizard.com
@physiowizard
Value Proposition:
PhysioWizard is the world’s first clinically validated, CE-marked, self-assessment app for patients with muscle & joint problems.
On Day 1, it routes patients to the appropriate treatment of care, and offers self-management, physiotherapy exercise videos & advice.
Physiowizard reduces the number of patients requiring face-face physiotherapy appointments, and the ability to replace clinically qualified telephone call handlers with non-qualified staff.
Customer Segments:
NHS CCGs, National Physiotherapy Providers, Private Health Insurance Providers, Corporate Wellbeing and Occupational Health Companies.
Market Traction:
Physiowizard was launched to the UK market in Dec 2018. It is currently being implemented with the largest physio network providers in the UK, with CCG’s in England, and about to be launched with corporate wellbeing programmes nationally. The business is also negotiating with US and Australian global insurance companies.
Awards:
BioCity Accelerator Programme Winner 2016.
Funding Stage:
Series A / Growth
Funding and Investment to Date:
£250k in December 2016 from Archangel Investments and the BioCity Investment Fund
Investment Secured:
£750k follow-on investment from Archangel Investments, Scottish Investment Bank and the BioCity Investment Fund.
DISCLAIMER
The purpose of this Investor Showcase is to provide information on the business described above. The Investor Showcase is not a prospectus and does not constitute or form any offer or invitation to subscribe for, underwrite, or purchase securities, nor shall the Investor Showcase or any part of it form the basis of, or be relied upon in connection with, any contract relating to any securities unless expressly included hereafter.
WARNING
The content of this Investor Showcase has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this Investor Showcase for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested.
Physiomedics Ltd
Management Team:
Garry Fingland, Chairman
Mark Roger, Director
Ross Haworth, Director
Kirsten Lord, Founder & Chief Clinical Officer
Web & Social Media:
www.physiowizard.com
@physiowizard
Value Proposition:
PhysioWizard is the world’s first clinically validated, CE-marked, self-assessment app for patients with muscle & joint problems.
On Day 1, it routes patients to the appropriate treatment of care, and offers self-management, physiotherapy exercise videos & advice.
Physiowizard reduces the number of patients requiring face-face physiotherapy appointments, and the ability to replace clinically qualified telephone call handlers with non-qualified staff.
Customer Segments:
NHS CCGs, National Physiotherapy Providers, Private Health Insurance Providers, Corporate Wellbeing and Occupational Health Companies.
Market Traction:
Physiowizard was launched to the UK market in Dec 2018. It is currently being implemented with the largest physio network providers in the UK, with CCG’s in England, and about to be launched with corporate wellbeing programmes nationally. The business is also negotiating with US and Australian global insurance companies.
Awards:
BioCity Accelerator Programme Winner 2016.
Funding Stage:
Series A / Growth
Funding and Investment to Date:
£250k in December 2016 from Archangel Investments and the BioCity Investment Fund
Investment Secured:
£750k follow-on investment from Archangel Investments, Scottish Investment Bank and the BioCity Investment Fund.
DISCLAIMER
The purpose of this Investor Showcase is to provide information on the business described above. The Investor Showcase is not a prospectus and does not constitute or form any offer or invitation to subscribe for, underwrite, or purchase securities, nor shall the Investor Showcase or any part of it form the basis of, or be relied upon in connection with, any contract relating to any securities unless expressly included hereafter.
WARNING
The content of this Investor Showcase has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this Investor Showcase for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested.
